摘要:
Isolated nucleic acids encoding allergens of the species Dermatophagoides pteronyssinus and Dermatophagoides farinae, Der p VII and Der f VII, respectively, are disclosed. A cDNA encoding a peptide having a Der p VII activity and a predicted molecular weight of about 22, 177 daltons is described. A cDNA encoding a peptide having Der f VII activity is also described. The nucleic acids of the invention can be used as probes to detect the presence of Der p VII or Der f VII nucleic acid in a sample or for the recombinant production of peptides having a Der p VII or Der f VII activity. Peptides having a Der p VII or Der f VII activity can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to house dust mite allergens.
摘要:
The present invention relates to recombinant eukaryotic plasmids comprising an eukaryotic expression vector and an allergen gene for the prevention and/or treatment of allergic diseases. When the recombinant vector containing allergen-gene administrate to an individual in need of such prevention and/or treatment by intramuscular injection, intranasal delivery or intratracheal delivery, the production of allergen-specific IgE synthesis can be inhibited. The invention also relates to the pharmaceutical compositions comprising the the recombinant vector for use in the the prevention and/or treatment of allergic diseases and the production of allergen-specific IgE synthesis. A method for the prevention and/or treatment of allergic diseases is also provided.
摘要:
Isolated DNA encoding allergens of Dermatophagoides (house dust mites) particularly of the species Dermatophagoides farinae and Dermatophagolides pteronyssinus, which are protein allergens or peptides which include at least one epitope of the protein allergen. In particular, DNA encoding two major D. farinae allergens, Der f I and Der f II and DNA encoding a D. pteronyssinus allergen, Der p I. In addition, the proteins or peptides encoded by the isolated DNA, their use as diagnostic and therapeutic reagents and methods of diagnosing and treating sensitivity to house dust mite allergens.
摘要翻译:编码Dermatophagoides(房尘螨)的变应原的分离的DNA,特别是Dermatophagoides farinae和Dermatophagolides pteronyssinus的物种,其是包括蛋白质变应原的至少一个表位的蛋白质过敏原或肽。 特别地,编码两个主要的D. farinae过敏原的DNA,Der f I和Der f II以及编码D.pteronyssinus变应原的DNA,Der p I.另外,由分离的DNA编码的蛋白质或肽,它们用作诊断和 诊断和治疗房屋尘螨过敏原敏感性的治疗试剂和方法。
摘要:
Isolated DNA encoding allergens of Dermatophagoides (house dust mites) particularly of the species Dermatophagoides farinae and Dermatophagoides pteronyssinus, which are protein allergens or peptides which include at least one epitope of the protein allergen. In particular, DNA encoding two major D. farinae allergens, Der f I and Der f II and DNA encoding a D. pteronssinus allergen, Der p I. In addition, the proteins or peptides encoded by the isolated DNA, their use as diagnostic and therapeutic reagents and methods of diagnosing and treating sensitivity to house dust mite allergens.
摘要翻译:编码Dermatophagoides(房尘螨)变应原的分离的DNA,特别是Dermatophagoides farinae和Dermatophagoides pteronyssinus,它们是蛋白质过敏原或包括蛋白质变应原的至少一个表位的肽。 特别地,编码两个主要的D. farinae变应原的Der DNA和Der f II以及编码D.pteronssinus变应原Der P的DNA。另外,由分离的DNA编码的蛋白质或肽,它们用作诊断和 诊断和治疗房屋尘螨过敏原敏感性的治疗试剂和方法。
摘要:
A novel protein allergen Der p VII of Dennatophagoides pteronyssinus is described. A cDNA clone encoding Der p VII was isolated from a .lambda.gt11 library of D. pteronyssinus cDNA. The nucleic acid sequence of der p VII encodes a 198 residue mature processed protein having a predicted molecular weight of 22,177 daltons. Der p VII protein may be used as the active ingredient in therapeutic composition for the treatment of sensitivity to house dust mites. The protein may also be used in methods of diagnosing such sensitivity.
摘要翻译:描述了Dennatophagoides pteronyssinus的新型蛋白质过敏原Der VII。 从D.pteronyssinus cDNA的λgt11文库中分离编码Der p VII的cDNA克隆。 衍生物VII的核酸序列编码具有预测分子量为22,177道尔顿的198残基成熟加工蛋白质。 Der p VII蛋白可用作治疗组合物中用于治疗房尘螨敏感性的活性成分。 该蛋白质也可用于诊断这种敏感性的方法。
摘要:
The present invention relates to recombinant eukaryotic plasmids comprising an eukaryotic expression vector and an allergen gene for the prevention and/or treatment of allergic diseases. When the recombinant vector containing allergen-gene is administered to an individual in need of such prevention and/or treatment by intramuscular injection, intranasal delivery or intratracheal delivery, the production of allergen-specific IgE synthesis can be inhibited. The invention also relates to the pharmaceutical compositions comprising the recombinant vector for use in the the prevention and/or treatment of allergic diseases and the production of allergen-specific IgE synthesis. A method for the prevention and/or treatment of allergic diseases is also provided.